Content Spotlight
UAE accelerates push to become world’s first AI-native government
Opportunity around the adoption of Agentic AI opens new doors for health tech startups and enterprise vendors.
Headlines
Explore latest insightsDubai Longevity Authority: Investment opportunities in UAE’s $8 trillion healthy ageing market
How Dubai's new regulatory framework creates unprecedented access for healthcare investors in regenerative medicine and longevity science
Jun 12, 2026
Healthcare ManagementNigeria health insurance shift: how micro-insurance is evolving into bundled care
Africa’s digital health market is projected to grow at 23.4% CAGR through 2030, and bundled care in Nigeria may become the mechanism that closes that gap.
Jun 1, 2026
Healthcare ManagementUAE streamlines healthcare licensing
New regulations enable academic professionals to work clinically while fast-tracking nursing and allied health graduates into the workforce.
May 12, 2026
Digital Magazine
Digital Magazine
WHX Insights Magazine 2026
The official editorial partner of WHX Dubai and WHX Labs Dubai.
Healthcare Management
View more
Subscribe to WHX Insights Newsletter
Stay at the forefront of healthcare trends & innovations
Medical Technology
In conversation with Cecilie Gudesen Torp, VP and Managing Director, Medical Technologies, Life Sciences, DNV.
Medical Technology
Data-Driven EHRs and AI for an Interoperable Digital Health EcosystemData-Driven EHRs and AI for an Interoperable Digital Health Ecosystem
In conversation with Romel Khalife, Country Manager – UAE and Kuwait, Oracle Health.
Medical Technology
UAE accelerates push to become world’s first AI-native governmentUAE accelerates push to become world’s first AI-native government
Opportunity around the adoption of Agentic AI opens new doors for health tech startups and enterprise vendors.
Medical Laboratory
You are monitoring a CML patient in sustained MMR. Suddenly, the BCR-ABL result comes back negative — or unexpectedly positive. Sound familiar? Discordant molecular results are not just lab curiosities. They are clinical decision points that demand systematic investigation. 1. Pre-analytical pitfalls Contamination causes false positives. One CMR patient can show an unexpected 0.04% IS positivity — traced to amplicon contamination in the pipetting area. 2. Analytical blind spots 2025 ELN recommendation : Assays must detect all clinically relevant variants. 3. Interpretation gaps Reports must flag technical limitations: "RNA degradation suspected" or "Rare transcript not targeted." ✓ Process samples within 24 hours ✓ Validate control gene performance (assess Ct values) ✓ Confirm transcript coverage in atypical/relapsed cases ✓ Repeat unexpected results with fresh specimens ✓ Correlate molecular data with CBC and morphology ✓ Implement IS calibration and participate in EQA schemes Discordant BCR-...
Medical Laboratory
By 2040, your lab will either lead the revolution — or become obsoleteBy 2040, your lab will either lead the revolution — or become obsolete
Clinical laboratories will transform into AI-powered, patient-centric ecosystems delivering real-time insights and personalised medicine.
Medical Laboratory
Market snapshot: Clinical trials market set for major growth through 2034Market snapshot: Clinical trials market set for major growth through 2034
The global clinical trials market is experiencing significant expansion, growing from US$59 billion in 2024 to a projected US$98.9 billion by 2034 — a steady 5.2% annual growth rate . Rising disease burden Outsourcing boom Strong funding support Asia Pacific emergence Regulatory complexity : Navigating multiple countries' varying rules and ethical standards remains time-consuming and costly. Patient recruitment: Many trials face delays due to under-enrolment, though digital platforms and decentralised trial models offer solutions. Clinical trials remain the backbone of medical innovation. For healthcare decision-makers, t he shift toward outsourcing, geographical diversification, and patient-centric designs presents strategic opportunities to reduce costs while improving outcomes.
